Chemistry and regulatory in drug development

被引：0
|
作者：
Charpentier, Bonnie A. [1 ]
机构：
[1] US & Metabolex Inc, Amer Chem Soc, Board Directors, Hayward, CA 94545 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
371-CHED
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
    Cheryl L. Rowe-Rendleman
    Pharmaceutical Research, 2019, 36
  • [32] Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review
    Mitra, Amitava
    Wang, Yaning
    PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1663 - 1667
  • [33] Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review
    Amitava Mitra
    Yaning Wang
    Pharmaceutical Research, 2022, 39 : 1663 - 1667
  • [34] Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
    Rowe-Rendleman, Cheryl L.
    PHARMACEUTICAL RESEARCH, 2019, 36 (04)
  • [35] Development and regulatory strategies for drug and diagnostic co-development
    Hinman, Lois M.
    Carl, Kevin M.
    Spear, Brian B.
    Salerno, Ronald A.
    Becker, Robert L.
    Abbott, Brian M.
    Kelly, James F.
    Mansfield, Elizabeth
    Katz, Russell G.
    Harper, Courtney
    Day, Stephen P.
    Pacanowski, Michael A.
    Pignato, William
    PHARMACOGENOMICS, 2010, 11 (12) : 1669 - 1675
  • [36] Drug Metabolism in Drug Development: A DIA Tutorial for Regulatory Affairs Specialists
    Peter K. Honig
    Louis R. Cantilena
    Kenneth S. Santone
    Drug information journal : DIJ / Drug Information Association, 1998, 32 (1): : 163 - 167
  • [37] Drug metabolism in drug development: A dia tutorial for regulatory affairs specialists
    Honig, PK
    Cantilena, LR
    Santone, KS
    DRUG INFORMATION JOURNAL, 1998, 32 (01): : 163 - 167
  • [38] SCIENTIFIC AND REGULATORY PERSPECTIVES ON DRUG INTERACTION EVALUATION DURING DRUG DEVELOPMENT
    Zhang, Lei
    DRUG METABOLISM REVIEWS, 2014, 45 : 18 - 18
  • [39] US regulatory approaches to chemistry, manufacturing, and controls for botanical drug products
    Rajiv Agarwal
    Journal of Translational Medicine, 10 (Suppl 2)
  • [40] BIOMOLECULAR CHEMISTRY DIRECTED TOWARDS DRUG DEVELOPMENT
    Martin, Rene
    Kirst, Juliane
    Weidlich, Sebastian
    Schieb, Heinke
    Schlechtingen, Georg
    Jaeger, A.
    Rajendran, Lawrence
    Boehl, Markus
    Richter, Sabine
    Fedorov, Roman
    Manstein, Dietmar J.
    Gutzeit, Herwig O.
    Klafki, Hans
    Wiltfang, Jens
    Simons, Kai
    Knoelker, Hans-Joachim
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S23 - S26
12345